Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Semaglutide offers a proven, slightly gentler entry point for those new to GLP-1 therapy or with sensitive digestive systems
J.GilliverS
Table of Contents Jardiance (Empagliflozin) Product Category Diabetes & Heart Failure SGLT2 Inhibitor Generic Name or Biosimilar No Active Ingredient Empagliflozin Prescription Status Prescription-only Targeted Conditions Jardiance is approved to treat the following conditions: Type 2 Diabetes Mellitus (T2DM), to improve glycemic control Heart Failure with Reduced Ejection Fraction (HFrEF), to reduce the risk of cardiovascular death and hospitalization Chronic Kidney Disease (CKD), to slow progression and improve renal outcomes Off-Label Usage Some off-label uses being studied or prescribed include: Heart Failure with Preserved Ejection Fraction (now formally approved) Type 1 Diabetes (investigational
Another important aspect is that, because compounding oversight is typically less stringent than for commercial drug manufacturers, the risk of substandard products is significantly higher
Michelle Pierce, 25, is a patient from Austin who also has relied on a compounded semaglutide to treat her PCOS
US$ 28.40
US$ 25.95
US$ 28.96
US$ 27.91
US$ 22.10
US$ 20.05
US$ 22.40
